Beckman Coulter, Inc. recalls Beckman Coulter IRISPEC CA/CB/CC Urine Chemistry Controls, Catalog Number REF 800-7211 and 800-7702, in vitro diagnosti…
- Recall date
- July 16, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0093-2025
- FDA classification
- Class III
- Brand / firm
- Beckman Coulter, Inc.
- Sold / distributed
- worldwide
Why it was recalled
Beckman Coulter has become aware of an increase in customer complaints for intermittent IRISpec CB negative glucose control failure, resulting in false positive control results when used in conjunction with iChemVELOCITY Urine Chemistry Strips (PNs 800-7204 and 800-7212) on the iChemVELOCITY Analyzer. This issue may delay the reporting of patient results, with a worst-case scenario of a delay in diagnosis or treatment of metabolic disorders, kidney function abnormalities, urinary tract infections, and liver function.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Beckman Coulter IRISPEC CA/CB/CC Urine Chemistry Controls, Catalog Number REF 800-7211 and 800-7702, in vitro diagnostic device.
Get recall alerts
Free email alert whenever Beckman Coulter, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Beckman Coulter, Inc.